
Kirkland Biotech's Hepatitis D Drug Reaches FDA Review
A Kirkland biotechnology company just hit a major milestone that could bring hope to thousands living with a rare liver disease. The FDA has accepted EIT Pharma's new drug application for treating chronic hepatitis D.














%3Amax_bytes(150000)%3Astrip_icc()%3Afocal(749x0%3A751x2)%2Fdeer-rescued-from-frozen-lake-5-020626-f44a8e6a9f3a4651a907b89235ed0742.jpg)


